Sentence examples for of having demonstrable from inspiring English sources

The absolute CD4 count correlated with the likelihood of having demonstrable IFN-γ responses to each mycobacterial antigen: ESAT-6, Pearson r = 0.1076, P < 0.0001; Ag85 Pearson r = 0.0488, P < 0.0356; and WCL Pearson r = -0.0868, P = 0.0002.

Which means you're going to be seeing a lot of the clip above, or variations on it, over the next few days: That and the Klinsmann/Joachim Löw coaching connection will have a lot of people jumping to conclusions about what might happen between two teams who only need a draw, with one of them having demonstrable history of tactical … discretion.

There is a growing emphasis on the importance of research having demonstrable public benefit.

A range of interventions have demonstrable efficacy in improving the lives of people experiencing such problems.

There are also 26 subjects who showed markers of a previous HBV infection (anti-HBs/anti-HBc), only one (4%) of whom had demonstrable hepatic HBV-DNA sequences.

In chronic disease, greater continuity of care has demonstrable benefit, a 50% reduction in hospital readmissions in CHF [ 43], reduced symptomatology in COPD [ 44] and our HT program's reduction in hospitalizations and other improved outcomes in late-stage CKD.

The patient with "normal" eGFR (subject 9) and 38% segmental glomerulosclerosis at the time of biopsy had demonstrable hyperfiltration at initial diagnosis (eGFR = 217 ml/min per 1.73 m) and has continued to have declining glomerular filtration rate in follow-up (at age 16 years, eGFR = 44 ml/min per 1.73 m).

I'm not referring to run of the mill product managers and UI developers or "social media experts," but rather that rare breed of people who have demonstrable experience leading users down the path to internet nirvana.

Some of these patients have demonstrable, long-lasting, possibly permanent deficits after discharge from the hospital.

As such, it is a crude indicator of heterogeneity by quantifying the proportion of a tumour that has demonstrable delivery and retention of contrast agent.

51.4% of all referred patients had demonstrable visual field loss with a prevalence of 52.3% for those formally recruited to the VIS study.